PACS Group (NYSE:PACS) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of PACS Group (NYSE:PACS) from a hold rating to a buy rating in a research report sent to investors on Sunday morning.

A number of other equities analysts have also commented on the stock. UBS Group reissued a “buy” rating and issued a $42.00 price target (down previously from $50.00) on shares of PACS Group in a research report on Thursday, December 18th. Weiss Ratings reiterated a “hold (c-)” rating on shares of PACS Group in a research note on Monday, December 22nd. Zacks Research raised shares of PACS Group from a “strong sell” rating to a “hold” rating in a research report on Friday, January 30th. Royal Bank Of Canada restated an “outperform” rating and set a $47.00 price target on shares of PACS Group in a report on Friday, December 19th. Finally, Truist Financial set a $40.00 price target on PACS Group in a research report on Friday, December 12th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, PACS Group has an average rating of “Moderate Buy” and a consensus price target of $43.25.

PACS Group Price Performance

Shares of NYSE:PACS opened at $41.03 on Friday. The stock has a market capitalization of $6.43 billion, a P/E ratio of 39.08, a P/E/G ratio of 1.26 and a beta of -0.65. The business has a 50-day moving average of $37.36 and a two-hundred day moving average of $22.86. PACS Group has a fifty-two week low of $7.50 and a fifty-two week high of $43.08. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.94 and a quick ratio of 0.94.

PACS Group (NYSE:PACS) last issued its quarterly earnings data on Wednesday, November 19th. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.36). PACS Group had a net margin of 3.29% and a return on equity of 21.39%. The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.11 billion. On average, equities research analysts predict that PACS Group will post 1.01 EPS for the current fiscal year.

Insider Activity

In other news, Director Evelyn S. Dilsaver purchased 16,724 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were purchased at an average cost of $29.90 per share, for a total transaction of $500,047.60. Following the completion of the purchase, the director directly owned 22,739 shares of the company’s stock, valued at approximately $679,896.10. The trade was a 278.04% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider John Todd Mitchell sold 159,556 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $29.89, for a total value of $4,769,128.84. Following the completion of the transaction, the insider directly owned 755,836 shares of the company’s stock, valued at approximately $22,591,938.04. This trade represents a 17.43% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 70.40% of the company’s stock.

Institutional Trading of PACS Group

Institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. lifted its position in PACS Group by 14.4% in the fourth quarter. Vanguard Group Inc. now owns 4,506,227 shares of the company’s stock worth $172,994,000 after purchasing an additional 566,502 shares during the period. Alyeska Investment Group L.P. raised its stake in shares of PACS Group by 159.5% in the 4th quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock valued at $86,378,000 after buying an additional 1,382,984 shares in the last quarter. Crewe Advisors LLC lifted its holdings in shares of PACS Group by 93.1% during the 4th quarter. Crewe Advisors LLC now owns 2,147,815 shares of the company’s stock worth $82,455,000 after acquiring an additional 1,035,747 shares during the period. Royce & Associates LP lifted its holdings in shares of PACS Group by 76.6% during the 3rd quarter. Royce & Associates LP now owns 1,859,070 shares of the company’s stock worth $25,525,000 after acquiring an additional 806,446 shares during the period. Finally, Balyasny Asset Management L.P. boosted its position in shares of PACS Group by 67.3% during the 3rd quarter. Balyasny Asset Management L.P. now owns 1,356,240 shares of the company’s stock valued at $18,621,000 after acquiring an additional 545,348 shares in the last quarter.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.